PARKINSON'S DISEASE PSYCHOSIS

Clinical trials for PARKINSON'S DISEASE PSYCHOSIS explained in plain language.

Never miss a new study

Get alerted when new PARKINSON'S DISEASE PSYCHOSIS trials appear

Sign up with your email to follow new studies for PARKINSON'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for controlling terrifying hallucinations in Parkinson's patients

Disease control Completed

This study tested whether the drug pimavanserin is safe and effective at reducing psychosis symptoms like hallucinations and delusions in people with Parkinson's disease. It involved 248 patients who took either the drug or a placebo (inactive pill) for 43 days. The goal was to s…

Matched conditions: PARKINSON'S DISEASE PSYCHOSIS

Phase: PHASE3 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

PARKINSON'S DISEASE PSYCHOSIS

Get alerted when new PARKINSON'S DISEASE PSYCHOSIS trials appear

New hope for controlling terrifying hallucinations in Parkinson's patients